Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?

What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus? Transplantation. 2009 Jan 27; 87(2):164-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.